Skip to content

Palvella Therapeutics

US · PVLA #2822 by market cap Listed 1970
130.59 +2.59 +2.02%
Live - 5344 symbols - heartbeat 393s ago · 2026-10-08 04:00
Pre-market 131.00 +0.31%
After-hours 130.70 +0.08%
Overnight 130.05 -0.41%
Market cap
1.88B
P/B
8.68
EPS
-3.71
Reader sentiment Are you bullish or bearish on PVLA?

Anonymous reader poll. Unscientific, not investment advice.

Palvella Therapeutics ended the session at 130.59, up 2.02%. The company carries a market value of roughly 1.88B, the #2822 most valuable US-listed company we track. Wall Street's 9-analyst consensus lands on Buy, with a price target averaging 235.22 (+80% from here). Over the past year the stock has ranged from 66.58 to 161.38; it now sits 68% up that band.

✦ StockVane Quant Insights how this is computed

Quant Rating B Buy
  • Twelve-month momentum in the top 7% of the universe, above its 200-day average.
  • Signal has read BUY for 6 months.
See the full rating history & follow-along return →
Quant Sentiment Bullish
  • Recent price momentum is +37.1% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 16.1% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Price chart

158.13102.19130.592026-04-092026-10-07
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60

Performance

1W -5.32%
1M -16.95%
3M -10.37%
6M +8.80%
YTD +24.76%
1Y +84.66%
3Y +423.20%
5Y -66.20%

Key statistics

Price & volume

Prev close
128.00
Open
125.97
Day range
125.00 - 131.35
Avg price
129.72
Volume
151.99K
Turnover
19.72M
Amplitude
4.96%
52-week range
66.58 - 161.38

Valuation

P/E
-35.20
P/E (TTM)
-26.93
P/B
8.68
EPS
-3.71
Net profit
-53.46M
Net assets
216.86M

Share structure

Market cap
1.88B
Float cap
1.39B
Shares out
14.41M
Float shares
10.68M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 68% of range
66.58 161.38

19.1% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-5.01M net over the window

Short interest

Shares short
2.33M
As of
2026-09-15

Frequently asked questions

What is the current stock price of Palvella Therapeutics (PVLA)?

Palvella Therapeutics last traded at 130.59. The quote on this page refreshes every few seconds while US markets are open.

What is Palvella Therapeutics's market cap?

About 1.88B.

What is the P/E ratio of Palvella Therapeutics?

The trailing twelve-month P/E is -26.93. The Valuation tab shows it against the stock's own five-year range.

Does Palvella Therapeutics pay a dividend?

Palvella Therapeutics does not currently pay a regular dividend.

Is Palvella Therapeutics a buy according to analysts?

The consensus of 9 analysts is a Buy rating, with an average 12-month price target of 235.22, which implies 80.1% upside from the current price. This is not investment advice.

What is Palvella Therapeutics's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Palvella Therapeutics a B (Buy). Twelve-month momentum in the top 7% of the universe, above its 200-day average. Not investment advice.

Quote time 2026-10-08 04:00:14 · For reference only, not investment advice and not tailored to your situation.